Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steve Zaniboni Insider Profile
4 Followers
Steve Zaniboni, CFO at Cardiff Oncology, holds 21.33K shares in Cardiff Oncology (Ticker: CRDF), holds 25.48M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Steve Zaniboni Bought ― shares of Cardiff Oncology on Apr 22, 2016 for an estimated value of 275.87K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+41.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steve Zaniboni holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steve Zaniboni
Steve Zaniboni's Trading History
Cardiff Oncology
Apr 22, 2016
CFO
Informative Buy
275.87K
$68.25K
Sorrento Therapeutics
Feb 05, 2010
Director, Ten Percent Owner
Informative Buy
―
$331.30K
List of latest transactions for each holding click on a transaction to see Steve Zaniboni's performance on stock
You May Also Like
Steve Zaniboni insider profile FAQ
What is the percentage of profitable transactions made by Steve Zaniboni?
The percentage of profitable transactions made by Steve Zaniboni is 33%.
What is the average return per transaction made by Steve Zaniboni?
The average return per transaction made by Steve Zaniboni is 41.40%.
What stocks does Steve Zaniboni hold?
Steve Zaniboni holds: CRDF, SRNE stocks.
What was Steve Zaniboni’s latest transaction?
Steve Zaniboni latest transaction was an Informative Buy of $275.87K.
What was Steve Zaniboni's most profitable transaction?
Steve Zaniboni’s most profitable transaction was an Informative Buy of CRDF stock on June 10, 2014. The return on the trade was 220.30%.
What is Steve Zaniboni's role in Cardiff Oncology?
Steve Zaniboni's role in Cardiff Oncology is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.